Revised Viagra Ad Will Debut In December
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer plans to resume its television advertising for Viagra in December after revising its "wild thing" campaign in response to objections raised by FDA, Worldwide Pharmaceuticals Group President Karen Katen said during Pfizer's Nov. 30 analysts meeting in Groton, Conn
You may also be interested in...
Viagra "Wild Thing" Ads Too Wild For FDA; Pfizer Will Pull Them
FDA declares that the ads, featuring a man with blue horns, cross the line and cannot be considered unbranded "reminder" ads. Pfizer says it will discuss FDA's concerns before deciding whether and how to resume the campaign.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.
Biden’s Co-Pay Cap Is Silver Lining For Pharma In Drug Pricing Campaign
President Biden’s call to expand the US Medicare price negotiation program is naturally making headlines from his campaign-year State of the Union Address. But his call for a national cap on co-pays could be an important opportunity for industry in the years to come.